Timing of changing therapy from gemcitabine and cisplatin chemotherapy based on real-world data of advanced urothelial carcinoma

Cisplatin-based systemic chemotherapy is the gold-standard approach for the first-line treatment of patients with advanced or metastatic urothelial carcinoma (UC). However, the optimal number of cycles is still unclear. The current study retrospectively assessed the clinical outcome in patients who...

Full description

Saved in:
Bibliographic Details
Published in:Oncol Lett
Main Authors: Furubayashi, Nobuki, Negishi, Takahito, Takamatsu, Dai, Ieiri, Kosuke, Inoue, Tomohiro, Tsukino, Keiji, Nakamura, Motonobu
Format: Artigo
Language:Inglês
Published: D.A. Spandidos 2020
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7074169/
https://ncbi.nlm.nih.gov/pubmed/32256805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.11368
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items